 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «12 |
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial initiation date: Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency (clinicaltrials.gov) - Aug 6, 2019
P=N/A, N=25, Not yet recruiting, Sponsor: Octapharma
Initiation date: May 2019 --> Oct 2019
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Enrollment closed, Trial primary completion date, Surgery: FORMA-04: Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency (clinicaltrials.gov) - Jul 30, 2019
P3, N=6, Active, not recruiting, Sponsor: Octapharma
Initiation date: May 2019 --> Oct 2019 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2020 --> Jun 2019
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial completion, Enrollment change, Head-to-Head, Surgery: FIBRES: FIBrinogen REplenishment in Surgery (clinicaltrials.gov) - May 14, 2019
P3, N=827, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2020 --> Jun 2019 Active, not recruiting --> Completed | N=1200 --> 827
- |||||| Fibryga (fibrinogen concentrate (human)) / Octapharma
New trial: Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency (clinicaltrials.gov) - Jan 4, 2019
P, N=25, Not yet recruiting, Sponsor: Octapharma
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Enrollment closed, Head-to-Head, Surgery: FIBRES: FIBrinogen REplenishment in Surgery (clinicaltrials.gov) - Nov 1, 2018
P3, N=1200, Active, not recruiting, Sponsor: University Health Network, Toronto
Active, not recruiting --> Completed | N=1200 --> 827 Recruiting --> Active, not recruiting
- |||| Fibryga (fibrinogen concentrate (human)) / Octapharma
New P2 trial, Surgery: Fibrinogen (blood protein) supplementation in patients that have developed fibrinogen deficiency during surgery. (EUDRACT) - Jul 19, 2018
P2, N=55, Ongoing, Sponsor: Octapharma AG
- || Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial completion, Trial completion date, Trial primary completion date, Surgery: FORMA-02: Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery (clinicaltrials.gov) - Jun 7, 2018
P3, N=25, Completed, Sponsor: Octapharma
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial completion date: May 2018 --> Jan 2018 | Trial primary completion date: May 2018 --> Jan 2018
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Enrollment closed, Trial completion date, Trial primary completion date, Surgery: FORMA-02: Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery (clinicaltrials.gov) - Apr 13, 2018
P3, N=24, Active, not recruiting, Sponsor: Octapharma
Active, not recruiting --> Completed | Trial completion date: May 2018 --> Jan 2018 | Trial primary completion date: May 2018 --> Jan 2018 Recruiting --> Active, not recruiting | Trial completion date: Oct 2019 --> May 2018 | Trial primary completion date: Oct 2019 --> May 2018
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial primary completion date, Surgery: FORMA-02: Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery (clinicaltrials.gov) - Oct 13, 2017
P3, N=24, Recruiting, Sponsor: Octapharma
Recruiting --> Active, not recruiting | Trial completion date: Oct 2019 --> May 2018 | Trial primary completion date: Oct 2019 --> May 2018 Trial primary completion date: Mar 2019 --> Oct 2019
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Enrollment open, Head-to-Head, Surgery: FIBRES: FIBrinogen REplenishment in Surgery (clinicaltrials.gov) - Mar 1, 2017
P3, N=1200, Recruiting, Sponsor: University Health Network, Toronto
Trial primary completion date: Mar 2019 --> Oct 2019 Not yet recruiting --> Recruiting
- || Fibryga (fibrinogen concentrate (human)) / Octapharma
New P3 trial, Head-to-Head, Surgery: FIBRES: FIBrinogen REplenishment in Surgery (clinicaltrials.gov) - Jan 30, 2017
P3, N=1200, Not yet recruiting, Sponsor: University Health Network, Toronto
- Fibryga (fibrinogen concentrate (human)) / Octapharma
Enrollment open, Surgery: FORMA-04: Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency (clinicaltrials.gov) - May 6, 2016
P3, N=6, Recruiting, Sponsor: Octapharma
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial initiation date, Surgery: FORMA-04: Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency (clinicaltrials.gov) - Oct 22, 2015
P3, N=6, Not yet recruiting, Sponsor: Octapharma
Not yet recruiting --> Recruiting Initiation date: Aug 2015 --> Dec 2015
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial completion, Enrollment change: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap (clinicaltrials.gov) - Oct 16, 2015
P2, N=22, Completed, Sponsor: Octapharma
Initiation date: Aug 2015 --> Dec 2015 Recruiting --> Completed | N=18 --> 22
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
New P3 trial, Surgery: FORMA-04: Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency (clinicaltrials.gov) - Apr 3, 2015
P3, N=6, Not yet recruiting, Sponsor: Octapharma
- Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial primary completion date: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap (clinicaltrials.gov) - Jan 7, 2015
P2, N=18, Recruiting, Sponsor: Octapharma
Recruiting --> Completed | N=18 --> 22 Trial primary completion date: Jul 2014 --> Jan 2015
- ||| Fibryga (fibrinogen concentrate (human)) / Octapharma
New P3 trial, Surgery: FORMA-02: Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery (clinicaltrials.gov) - Oct 17, 2014
P3, N=24, Recruiting, Sponsor: Octapharma
- Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial primary completion date: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap (clinicaltrials.gov) - Jun 24, 2014
P2, N=18, Recruiting, Sponsor: Octapharma
Trial primary completion date: Jul 2014 --> Jan 2015 Trial primary completion date: Mar 2014 --> Jul 2014
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Enrollment open: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap (clinicaltrials.gov) - Jul 8, 2013
P2, N=18, Recruiting, Sponsor: Octapharma
Trial primary completion date: Mar 2014 --> Jul 2014 Not yet recruiting --> Recruiting
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
Trial initiation date: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap (clinicaltrials.gov) - Feb 21, 2013
P2, N=18, Recruiting, Sponsor: Octapharma
Not yet recruiting --> Recruiting Initiation date: Oct 2012 --> Mar 2013
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
New P2 trial: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap (clinicaltrials.gov) - Apr 9, 2012
P2, N=18, Recruiting, Sponsor: Octapharma